Avidity Biosciences, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of RNA for the last quarter is 2.04 M USD, and it's 42.28% lower compared to the previous quarter. The net income of Q2 24 is -70.79 M USD.